This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Solent Therapeutics, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Feng Zhou
Introduction
Feng Zhou is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is characterized by a focus on innovative solutions for treating diseases associated with MRGX2.
Latest Patents
Feng Zhou holds a patent for "3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2." This patent discloses compounds of Formula (1), including tautomers and pharmaceutically acceptable salts. The compounds are designed to be used in pharmaceutical compositions for treating various diseases, disorders, or conditions linked to MRGX2.
Career Highlights
Feng Zhou is currently employed at Solent Therapeutics, LLC, where he continues to advance his research and development efforts. His innovative approach has led to the creation of valuable compounds that have the potential to improve patient outcomes in the medical field.
Collaborations
Feng Zhou collaborates with talented professionals such as Simone Bigi and Alison L Chambers. Their combined expertise enhances the research and development process, fostering an environment of innovation and discovery.
Conclusion
Feng Zhou's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile